70 0

Keratinocytic Vascular Endothelial Growth Factor as a Novel Biomarker for Pathological Skin Condition

Title
Keratinocytic Vascular Endothelial Growth Factor as a Novel Biomarker for Pathological Skin Condition
Author
배옥남
Keywords
Vascular endothelial growth factor (VEGF); Biomarker; Keratinocytic damage; Dermal toxicity; PERMEABILITY FACTOR; FACTOR EXPRESSION; ULTRAVIOLET-B; VEGF-C; EPIDERMAL-KERATINOCYTES; ATOPIC-DERMATITIS; FACTOR-ALPHA; FACTOR GENE; CULTURED KERATINOCYTES; HACAT KERATINOCYTES
Issue Date
2015-01
Publisher
KOREAN SOC APPLIED PHARMACOLOGY
Citation
BIOMOLECULES & THERAPEUTICS, v. 23, No. 1, Page. 12-18
Abstract
Skin is an emerging target tissue in pharmaceutical and cosmetic science. Safety assessment for dermal toxicity is a critical step for development of topically applicable pharmaceutical agents and ingredients in cosmetics. Urgent needs exist to set up toxicity testing methods for dermal safety, and identification of novel biomarkers for pathological cutaneous alteration is highly required. Here we will discuss if vascular endothelial growth factor (VEGF) has a potential as a biomarker for dermal impairment. Experimental and clinical evidences for induction of keratinocytic VEGF under pathological conditions will be reviewed.
URI
http://www.biomolther.org/journal/view.html?volume=23&number=1&spage=12&year=2015https://repository.hanyang.ac.kr/handle/20.500.11754/100629
ISSN
1976-9148; 2005-4483
DOI
10.4062/biomolther.2014.102
Appears in Collections:
COLLEGE OF PHARMACY[E](약학대학) > PHARMACY(약학과) > Articles
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE